{"id":9561,"date":"2024-09-26T19:12:05","date_gmt":"2024-09-26T16:12:05","guid":{"rendered":"https:\/\/yalovasondakika.com.tr\/?p=9561"},"modified":"2024-09-26T19:12:05","modified_gmt":"2024-09-26T16:12:05","slug":"daiichi-sankyo-turkiye-onkoloji-is-birimini-kurdu","status":"publish","type":"post","link":"https:\/\/yalovasondakika.com.tr\/index.php\/2024\/09\/26\/daiichi-sankyo-turkiye-onkoloji-is-birimini-kurdu\/","title":{"rendered":"Daiichi Sankyo T\u00fcrkiye, Onkoloji \u0130\u015f Birimini Kurdu"},"content":{"rendered":"<p><strong>Kardiyovask\u00fcler hastal\u0131klar alan\u0131ndaki g\u00fcvenilir \u00e7al\u0131\u015fmalar\u0131ndan ald\u0131\u011f\u0131 g\u00fc\u00e7le onkoloji portf\u00f6y\u00fcn\u00fc de T\u00fcrkiye\u2019deki hastalar\u0131n hizmetine sunmaya ba\u015flayan \u015firket, meme kanseri tedavisinde hastalara umut olacak yenilik\u00e7i \u00fcr\u00fcn\u00fcn\u00fc T\u00fcrk t\u0131bb\u0131n\u0131n hizmetine sundu.<\/strong><\/p>\n<p>120 y\u0131l\u0131 a\u015fan bilimsel uzmanl\u0131\u011f\u0131ndan ald\u0131\u011f\u0131 g\u00fc\u00e7le s\u0131n\u0131f\u0131nda \u00f6nc\u00fc ila\u00e7 ve y\u00f6ntemler geli\u015ftiren, Japonya\u2019n\u0131n en b\u00fcy\u00fck ila\u00e7 firmalar\u0131ndan biri olan Daiichi Sankyo, T\u00fcrkiye\u2019nin de i\u00e7inde bulundu\u011fu 20\u2019den fazla \u00fclkede ya\u015fam kalitesinin art\u0131r\u0131lmas\u0131na katk\u0131da bulunmaya kendini ad\u0131yor. Bu kapsamda, dokundu\u011fu hayatlarda her g\u00fcn bir fark yaratmak \u00fczere \u00e7al\u0131\u015fan Daiichi Sankyo T\u00fcrkiye, onkoloji i\u015f birimini kurarak kanser tedavisinde meme kanseri \u00fcr\u00fcn\u00fc ile onkoloji alan\u0131nda da faaliyet g\u00f6stermeye ba\u015flad\u0131.<\/p>\n<p>Toplumun s\u00fcrd\u00fcr\u00fclebilir geli\u015fimine katk\u0131da bulunan global ve yenilik\u00e7i bir sa\u011fl\u0131k kurulu\u015fu olma vizyonuyla sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri geli\u015ftiren Daiichi Sankyo T\u00fcrkiye, uzun d\u00f6nemde do\u011facak k\u00fcresel ihtiya\u00e7lar\u0131 tespit ederek \u00e7al\u0131\u015fmalar\u0131n\u0131 \u015fekillendiriyor. T\u00fcrkiye\u2019de kardiyoloji alan\u0131nda uzun y\u0131llard\u0131r g\u00fcvenilir bir \u00e7\u00f6z\u00fcm orta\u011f\u0131 olarak hizmet veren \u015firket, t\u00fcm d\u00fcnyada onkolojik \u00fcr\u00fcn merkezli Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 g\u00f6zlemlemi\u015f ve bu alanda olu\u015fan ihtiyac\u0131 tespit ederek ilk olarak meme kanseri hastal\u0131\u011f\u0131nda olmak \u00fczere onkoloji alan\u0131ndaki portf\u00f6y\u00fcn\u00fc T\u00fcrkiye\u2019deki hastalar\u0131n kullan\u0131m\u0131na sunmu\u015ftur.\u00a0<\/p>\n<p>Kar\u015f\u0131lanmam\u0131\u015f ihtiya\u00e7lara cevap veren sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri \u00fcretmek hedefiyle faaliyetlerini s\u00fcrd\u00fcren\u00a0<strong>Daiichi Sankyo T\u00fcrkiye\u2019nin \u00dclke M\u00fcd\u00fcr\u00fc\u00a0Nazl\u0131 Kay\u0131n,\u00a0<\/strong>onkoloji alan\u0131ndaki yenilik\u00e7i \u00fcr\u00fcnleriyle alana yeni bir ad\u0131m atman\u0131n mutlulu\u011funu ve gururunu ya\u015fad\u0131klar\u0131n\u0131 payla\u015farak\u00a0<em>\u201cDaiichi Sankyo olarak, her hasta yolculu\u011funun benzersiz ve g\u00f6r\u00fcnd\u00fc\u011f\u00fcnden \u00e7ok daha derin oldu\u011funa inan\u0131yoruz. Bu zorlu s\u00fcre\u00e7te hasta ve hasta yak\u0131nlar\u0131n\u0131n ihtiya\u00e7lar\u0131na en iyi \u015fekilde yan\u0131t vermek amac\u0131yla \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 ekip olarak azimle s\u00fcrd\u00fcr\u00fcyoruz. Yenilik\u00e7i antikor-ila\u00e7 konjugatlar\u0131 (ADC) platform teknolojisiyle t\u00fcm\u00f6r tiplerine y\u00f6nelik geli\u015ftirdi\u011fimiz ileri d\u00fczey bir tedavi y\u00f6ntemiyle ADC teknolojisindeki yedi temel s\u0131n\u0131rlamay\u0131 a\u015fmay\u0131 ba\u015fard\u0131k. Kanser tedavisindeki bu olumlu geli\u015fme ile T\u00fcrkiye\u2019deki hastalar\u0131n hizmetine yeni \u00fcr\u00fcn\u00fcm\u00fcz\u00fc sunmaktan dolay\u0131 \u00e7ok heyecanl\u0131y\u0131z\u201d<\/em>\u00a0dedi.<\/p>\n<p>De\u011fi\u015fen, d\u00f6n\u00fc\u015fen ve farkl\u0131la\u015fan t\u0131bbi ihtiya\u00e7lara yan\u0131t veren yenilik\u00e7i tedavi y\u00f6ntemleri geli\u015ftirme oda\u011f\u0131yla yapt\u0131\u011f\u0131 her i\u015fin merkezine \u00f6nce insan\u0131 konumlayan Daiichi Sankyo T\u00fcrkiye, \u201c7 y\u0131lda 8 yenilik\u00e7i onkolojik \u00fcr\u00fcn\u00fcn hastalar\u0131n kullan\u0131m\u0131na sunulmas\u0131\u201d hedefiyle onkoloji alan\u0131ndaki tutkusunu ortaya koyuyor.<\/p>\n<p>Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u00fcnya genelinde insanlar\u0131n ya\u015fam kalitesini art\u0131rmaya katk\u0131da bulunmak amac\u0131yla t\u0131bbi ihtiya\u00e7lara y\u00f6nelik yenilik\u00e7i sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri geli\u015ftiren Daiichi Sankyo, T\u00fcrkiye\u2019deki faaliyet alan\u0131n\u0131 geni\u015fletmeye devam ediyor.<\/p>\n","protected":false},"author":1,"featured_media":9562,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[3395,678,3394,336,820],"class_list":["post-9561","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-alaninda","tag-hasta","tag-onkoloji","tag-turk","tag-urun"],"_links":{"self":[{"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/9561"}],"collection":[{"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=9561"}],"version-history":[{"count":1,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/9561\/revisions"}],"predecessor-version":[{"id":9563,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/9561\/revisions\/9563"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/media\/9562"}],"wp:attachment":[{"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=9561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=9561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/yalovasondakika.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=9561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}